Sedighi et al. showed that the serum level of Matric metalloproteinase (MMP)-13 in ESCC patients were significantly higher than in the control group, and suggested that the MMP-13 was associated with increasing ESCC invasion, lymph node involvement and decreased survival rates [8]. This evidence concerns the gene MMP13 and esophageal squamous cell carcinoma.